Evidence map›Paper›PMID 41636473›Full record

ArticleHuman vaccines & immunotherapeutics2026

Impact of intralesional tuberculin PPD injection on anogenital warts: Interferon-α, interleukin-2, and treatment outcomes.

Pati Aji Achdiat, Oki Suwarsa, Yudi Mulyana Hidayat, Reiva Farah Dwiyana, Mohamad Nasir Shafiee, Reti Hindritiani, Endang Sutedja, Satiti Retno Pudjiati, Dany Hilmanto, Ida Parwati and 4 more

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Pati Aji AchdiatDepartment of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.ORCID 0000-0002-3010-5052
Oki SuwarsaDepartment of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.ORCID 0000-0003-4017-9319
Yudi Mulyana HidayatDoctoral Program in Medical Sciences, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.ORCID 0000-0002-8010-5907
Reiva Farah DwiyanaDepartment of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.ORCID 0000-0001-9350-0239
Mohamad Nasir ShafieeDepartment of Obstetrics and Gynecology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.ORCID 0000-0001-5631-5309
Reti HindritianiDepartment of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.ORCID 0000-0002-9753-0387
Endang SutedjaDepartment of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.ORCID 0000-0002-6960-4895
Satiti Retno PudjiatiDepartment of Dermatology and Venereology, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.ORCID 0000-0001-9235-759X
Dany HilmantoDoctoral Program in Medical Sciences, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.ORCID 0000-0003-3684-4144
Ida ParwatiDoctoral Program in Medical Sciences, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
Meita DhamayantiDoctoral Program in Medical Sciences, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.ORCID 0000-0001-9661-0708
Reyshiani JohanDepartment of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.ORCID 0009-0004-0843-998X
Ivan Daniel BanjarnahorDepartment of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.ORCID 0000-0001-7644-0510
Retno Hesty MaharaniDepartment of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.ORCID 0000-0002-4483-3552

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical manifestation of anogenital warts (AGW) resulting from Human Papillomavirus (HPV) infection is influenced by host immune responses. Interferon (IFN)-α contributes to antiviral activity, while Interleukin (IL)-2 plays an important role in cellular immunity. Tuberculin purified protein derivative (TPPD) has been investigated as an immunotherapeutic agent. This exploratory quasi-experimental study analyzed 12 AGW patients treated with intralesional TPPD (5 tuberculin units weekly for six injections). Tissue samples were collected at baseline and week 2, and serum samples at baseline and week 6. IFN-α and IL-2 expression in tissue was assessed using immunohistochemistry (IHC), and serum levels were measured using ELISA. TPPD therapy was associated with increased IFN-α and IL-2 expression in tissue (

Indexed as

Condylomata AcuminataInterferon-alphaInterleukin-2TuberculinAdolescentAdultEnzyme-Linked Immunosorbent AssayFemaleHumansImmunohistochemistryInjections, IntralesionalMaleTreatment OutcomeYoung AdultInterferon-alphaInterleukin-2TuberculinAnogenital wartsimmunohistochemistryimmunotherapyinterferon-αinterleukin-2serumtreatment responsetuberculin purified protein derivative

Identifiers

PMID41636473
PMCPMC12885424

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.